ADP-ribosyl cyclase (ADPR-cyclase) produces a Ca 2+ -mobilizing second messenger cyclic ADP-ribose (cADPR) from NAD + . In this study, we investigated the molecular basis of ADPR-cyclase activation and the following cellular events in angiotensin II (ANG II) signaling in mouse mesangial cells (MMCs). Treatment of MMCs with ANG II induced an increase in intracellular Ca 2+ concentrations through a transient Ca 2+ release via an inositol 1,4,5-trisphosphate receptor and a sustained Ca 2+ influx via L-type Ca 2+ channels. The sustained Ca 2+ signal, but not the transient Ca 2+ signal, was blocked by a cADPR antagonistic analog, 8-bromo-cADPR (8-Br-cADPR), and an ADPR-cyclase inhibitor, 4,4′-dihydroxyazobenzene (DHAB). In support of the results, ANG II stimulated cADPR production in a time-dependent manner, and DHAB inhibited ANG II-induced cADPR production. Application of pharmacological inhibitors revealed that activation of ADPR-cyclase by ANG II involved ANG II type 1 receptor, phosphoinositide 3-kinase, protein tyrosine kinase, and phospolipase C-γ1. Moreover, DHAB as well as 8-Br-cADPR abrogated ANG II-mediated Akt phosphorylation, nuclear translocation of nuclear factor of activated T cell, and uptake of [ 3 H]thymidine and [ 3 H]leucine in MMCs. These results demonstrate that ADPR-cyclase in MMCs plays a pivotal role in ANG II signaling for cell proliferation and protein synthesis.
All Science Journal Classification (ASJC) codes